David Hasl, MD
Surgery · Lancaster, OHNPI 1710978424
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,000 of the $12,177 with a category attached, or 82.1%. Intuitive Surgical accounts for 92.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $6,195 and has fallen 97.5% since, to $156 in 2025.
Across 55 payments — averaging $221.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Davol Inc.$133
- Sanofi$124
- BD$116
- Steris Corporation$81
- Pacira Pharmaceuticals Incorporated$74
- plus $395 from 14 others
What the payments were for
- Travel & lodging$7866%
- Food & beverage$1,39111%
- Education$10,00082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 31 | $11,254 |
| Davol Inc. | 1 | $133 |
| Sanofi | 2 | $124 |
| BD | 1 | $116 |
| Steris Corporation | 1 | $81 |
| Pacira Pharmaceuticals Incorporated | 3 | $74 |
| Stryker | 1 | $70 |
| Baxter Healthcare | 2 | $51 |
| Boston Scientific | 1 | $37 |
| Wound Management Technologies, Inc | 1 | $34 |
| Merck | 2 | $31 |
| Johnson & Johnson | 1 | $29 |
| Sanara Medtech Inc. | 1 | $23 |
| Kerecis Limited | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $21 |
| TELA Bio, Inc. | 1 | $17 |
| Avanos Medical | 1 | $13 |
| Elucent Medical | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$4,867
- PROGEL$116
- DUPIXENT$102
How this compares
$12,177 in reported general payments places this provider in the 80th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 23 | $333 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $133 |
Paid to pharmacies, not to this prescriber.
Other surgery in Lancaster
- Jeffrey YencharLancaster$32K
- Jonathan ThompsonWest Chester$2.1M
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Michael MearaColumbus$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Greg StarleyCuyahoga Falls$594K
- Ihya GorgunCleveland$527K
- Marshall SpaldingColumbus$450K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.